Two‐Dose versus Monthly Intermittent Preventive Treatment of Malaria with Sulfadoxine‐Pyrimethamine in HIV‐Seropositive Pregnant Zambian Women
Author(s) -
Davidson H. Hamer,
Victor Mwanakasale,
William MacLeod,
Victor Chalwe,
Doreen Mukwamataba,
Davies Champo,
Lawrence Mwananyanda,
Roma Chilengi,
Lwambwa Mubikayi,
Chikuli Kabika Mulele,
Modest Mulenga,
Donald M. Thea,
Christopher Gill
Publication year - 2007
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/522142
Subject(s) - medicine , malaria , parasitemia , sulfadoxine , sulfadoxine/pyrimethamine , regimen , pregnancy , obstetrics , low birth weight , mefloquine , immunology , pyrimethamine , chloroquine , plasmodium falciparum , biology , genetics
Intermittent preventive treatment of malaria during pregnancy (IPTp) reduces placental infection, maternal anemia, and low birth weight (LBW). However, the optimal dosing regimen in settings in which human immunodeficiency virus (HIV) is highly prevalent among pregnant women remains controversial.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom